mRNA processing in cancer immunotherapy: emerging targets, resistance mechanisms, and therapeutic opportunities
Cancer immunotherapy has improved outcomes across many tumor types, but primary and acquired resistance, tumor heterogeneity and a shortage of safe targets remain unresolved. Part of this gap arises because tumor cells evade immune recognition not only…